Return
Company Page
Mammogen
Mammogen is a female-led, venture-backed women's health diagnostics company developing RNA-powered molecular diagnostics for the noninvasive early detection of breast cancer. Its flagship product, genTRU-breast, is a blood-based RNA liquid biopsy test targeting Stage I breast cancer diagnosis, particularly in women with dense breast tissue where mammograms are less effective. The company is a subsidiary of IV BioHoldings and is advancing a pivotal prospective clinical program alongside commercialization expansion.
Company Founded in 2020
Healthtech & Biotech